TulikaRanjanMD

Neurology • Tampa, FL

Neurooncology

Director of Neuro-Oncology

Join to view full profile

Dr. Ranjan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ranjan's full profile

Already have an account?

Office
10740 Palm River Rd
Ste 360
Tampa, FL 33619
Phone+1 813-844-7585

Fax+1 412-359-6625

Education & Training

Rutgers Health/New Jersey Medical SchoolResidency, Neurology, 2004 - 2008
Sri Krishna Medical College Class of 2002

Certifications & Licensure

CA State Medical License 2008 - Present
FL State Medical License 2021 - 2026
NH State Medical License 2024 - 2026
VT State Medical License 2024 - 2026
PA State Medical License 2015 - 2022
NC State Medical License 2012 - 2015
NY State Medical License 2008 - 2014
NJ State Medical License 2005 - 2009
American Board of Psychiatry and Neurology Neurology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma Start of enrollment: 2018 May 20
Completed
Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Start of enrollment: 2019 Jul 30
Recruiting
Phase 2, Phase 3

Publications & Presentations

PubMed

Emerging Therapies for Brain Metastases in NSCLC, Breast Cancer, and Melanoma: A Critical Review.
Vivek Podder, Tulika Ranjan, Maya Gowda, Alejandra M Camacho, Manmeet S Ahluwalia
Current Neurology and Neuroscience Reports. 2024-12-03
20 citations
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu
Cell Reports. Medicine. 2023-05-16
3 citations
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients' healthcare costs.
Tulika Ranjan, Alexander Yu, Shaed Elhamdani, Candace M Howard, Seth T Lirette
Neuro-Oncology Advances. 2023-05-12

Lectures

Prospective analysis of cancer stem cell drug response assay for glioblastoma patients.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Diagnosis for 1.30.22: Checking the Pulse of Florida Health Care News and PolicyJanuary 30th, 2022